Theriva Biologics, Inc. (TOVX) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$17.07M2013: -$12.32M2014: -$19.78M2015: -$44.78M2016: -$27.80M2017: -$15.49M2018: -$13.42M2019: -$15.38M2020: -$10.12M2021: -$14.27M2022: -$19.68M2023: -$18.35M2024: -$25.65M2025: -$23.74M-$23.74M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$23.74M+7.5%
2024-$25.65M-39.8%
2023-$18.35M+6.8%
2022-$19.68M-38.0%
2021-$14.27M-41.0%
2020-$10.12M+34.2%
2019-$15.38M-14.6%
2018-$13.42M+13.4%
2017-$15.49M+44.3%
2016-$27.80M+37.9%
2015-$44.78M-126.4%
2014-$19.78M-60.6%
2013-$12.32M+27.8%
2012-$17.07M